Fritextsökning
Innehållstyper
-
Business Sweden’s new team is rolling out the blue-yellow carpet
According to Business Sweden’s life science team, the combination of substantial medical know-how and an ever-flourishing tech sector is a success factor for Sw...
-
Granskar Mylan-budet
Investeringsbolaget VEB undersöker om budet på svenska Meda bryter mot lagen.
-
Accurate removal of prostate tissue
Medical robots play an important role in diagnostics
-
Immunterapi väcker uppståndelse
En immunterapi mot leukemi har väckt stor uppmärksamhet efter rapporter om att mer än 90 procent av patienterna med terminal cancer blev bättre.
-
Efter misslyckad Parkinsonstudie – nu byter Irlab ut vd:n
Forskningsbolaget Irlab petar sin vid Richard Godfrey med omedelbar verkan. "Styrelsen har nått slutsatsen att ett skifte på vd-posten är det bästa för bolaget"...
-
Fewer visitors but satisfied exhibitors
Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.
-
Sanofi sparkar sin vd
Den franska läkemedelskoncernen gör sig av med koncernchefen Christopher A Viebacher.
-
Quiet, fast, inexpensive: mass flow controller for life sciences
Whether in portable oxygen system devices or in bioreactors, the new proportional flow control valve VEMD from Festo provides extremely high control dynamics an...
-
Teva i miljardaffär
Köper amerikanska Auspex för nära 26 miljarder kronor, och letar efter nya förvärv.
-
Extensive agreements signed at Scilifelab
Four agreements were signed between Swedish and Dutch life science players in connection with the Dutch state visit earlier this month.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Study names with an attitude – more important than you might think
Ironman, T-rex, Star-Trek. Popcorn, Proper, Scout. Nope, these are neither fantasy films nor dog names. They’re the names of ongoing cancer studies in Sweden.
-
Meda utvärderar verksamheten i USA
Kommenterar rykten om försäljning av den amerikanska verksamheten.
-
Marie Gårdmark: Potential step change – EU regulators get to play with data
A new pilot from EMA is starting in September to assess wether the analysis of 'raw data' by regulatory authorities improves the evaluation of marketing approval for new medicines. Marie Grådmark writes in a column that she is looking forward...
-
Nordic Regulatory experts: Improving biotech chances of Succ
Why is it that so many biotech companies fail? And what are the tools needed to change that fact?
-
Pfizer drar tillbaka Allergan-budet
Läkemedelsjätten drar tillbaka jättebudet efter nya förslag mot skatteinversion för amerikanska bolag.
-
No longer afraid of the dentist.
Teaching robot with piezo technology
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Neanderthal gene variants may cause Viking disease
A new study suggests that the so-called Viking disease, which affects the hand function in many older people, may be linked to gene variants inherited from Neanderthals.
-
Integrated solutions for liquid handling
Greater efficiency for manufacturers in laboratory automation and many other industries
-
Academia - a strong player on the lab market
While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia incre...
-
Anders Blanck about his 17 years at Lif: “The industry is enjoying greater public trust now"
The announcement came as a surprise to those around him, but according to the protagonist himself, the timing was excellent. Anders Blanck is now leaving Lif – ...
-
Pfizer-vd spår lägre FoU-satsningar
Under tisdagen och onsdagen denna vecka håller det brittiska parlamentet en hearing med företrädare från Pfizer och Astrazeneca med anledning av budvändorna.
-
Google satsar på diagnostik
Utvecklar sökverktyg för kroppen.
BREAKING